Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Armstrong

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2010
In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregationP C J Armstrong, P D Leadbeater, M V Chan, et al.
Thrombosis and Haemostasis|October 7, 2009
Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectivenessPaul C J Armstrong, Al-Rehan Dhanji, Nicola J Truss, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 20, 2009
Antiplatelet actions of statins and fibrates are mediated by PPARsFerhana Y Ali, Paul C J Armstrong, Al-Rehan A Dhanji, et al.
British Journal of Pharmacology|July 24, 2010
Nucleotide oligomerization domain 1 is a dominant pathway for NOS2 induction in vascular smooth muscle cells: comparison with Toll-like receptor 4 responses in macrophagesL Moreno, S K McMaster, T Gatheral, et al.
British Journal of Clinical Pharmacology|November 13, 2015
P2Y12 receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activationMelissa V Chan, Rebecca B M Knowles, Martina H Lundberg, et al.
Gene Therapy|February 11, 2011
Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanomaJ C Steele, A Rao, J R Marsden, et al.
Plos One|May 10, 2011
GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitorsHouyuan Hu, Paul C J Armstrong, Elie Khalil, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2008
Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2P C J Armstrong, N J Truss, F Y Ali, et al.
Circulation|December 11, 2014
Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugsBlerina Ahmetaj-Shala, Nicholas S Kirkby, Rebecca Knowles, et al.
Circulation|October 28, 2015
Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"Blerina Ahmetaj-Shala, Nicholas S Kirkby, Rebecca Knowles, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2010
In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregationP C J Armstrong, P D Leadbeater, M V Chan, et al.
Thrombosis and Haemostasis|October 7, 2009
Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectivenessPaul C J Armstrong, Al-Rehan Dhanji, Nicola J Truss, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 20, 2009
Antiplatelet actions of statins and fibrates are mediated by PPARsFerhana Y Ali, Paul C J Armstrong, Al-Rehan A Dhanji, et al.
British Journal of Pharmacology|July 24, 2010
Nucleotide oligomerization domain 1 is a dominant pathway for NOS2 induction in vascular smooth muscle cells: comparison with Toll-like receptor 4 responses in macrophagesL Moreno, S K McMaster, T Gatheral, et al.
British Journal of Clinical Pharmacology|November 13, 2015
P2Y12 receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activationMelissa V Chan, Rebecca B M Knowles, Martina H Lundberg, et al.
Gene Therapy|February 11, 2011
Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanomaJ C Steele, A Rao, J R Marsden, et al.
Plos One|May 10, 2011
GPVI and GPIbα mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitorsHouyuan Hu, Paul C J Armstrong, Elie Khalil, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2008
Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2P C J Armstrong, N J Truss, F Y Ali, et al.
Circulation|December 11, 2014
Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugsBlerina Ahmetaj-Shala, Nicholas S Kirkby, Rebecca Knowles, et al.
Circulation|October 28, 2015
Reply to letter regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"Blerina Ahmetaj-Shala, Nicholas S Kirkby, Rebecca Knowles, et al.
Pageof 2